Sign In
17 Jul 2013 08:01
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
PDMR / Director Shareholding
Sphere Medical Holding plc (AIM: SPHR.L), a leading developer of innovative monitoring and diagnostic products for the critical care setting, announces that 22,403,016 New Ordinary Shares issued in connection with the Placing, Subscription and Open Offer have today been admitted to trading on AIM. Following Admission, the Company now has 59,208,660 Ordinary Shares in issue.
Pursuant to the fundraising, the Directors of the Company have the following beneficial holdings in the Company:
Name of Director | Number of Ordinary shares acquired | Purchase price of shares | Total number of Ordinary Shares | Percentage of Issued Share Capital |
Dr Anthony Martin | 51,123 | 40p | 230,054 | 0.39% |
Dr Stuart Hendry | 26,653 | 40p | 119,940 | 0.20% |
Matthew Hall | 3,089 | 40p | 13,899 | 0.02% |
John Gregory | 9,749 | 40p | 43,870 | 0.07% |
Stephen H. Mahle | 13,142 | 40p | 59,138 | 0.10% |
For further information, please contact:
Sphere Medical Holding plc | Tel: +44 (0)1223 875222 | |
Dr Stuart Hendry, Chief Executive Officer | ||
Matthew Hall, Chief Financial Officer | ||
Peel Hunt LLP | Tel: +44 (0) 20 7418 8900 | |
James Steel | ||
Dr Vijay Barathan | ||
M:Communications Mary-Jane Elliott, Amber Bielecka, Hollie Vile | Tel: +44 (0) 20 7920 2333 spheremedical@mcomgroup.com | |
| ||
About Sphere Medical
Sphere Medical (AIM: SPHR.L), is a medical device company developing a range of innovative monitoring and diagnostic devices designed to significantly improve patient care.
Sphere Medical's Proxima and Cardiopulmonary Bypass devices deliver real time analysis of blood gases, electrolytes, glucose and drug levels with laboratory accuracy, at the patient's bedside. Globally over 240 million blood gas and electrolyte tests are carried out on patients every year in critical care and there is an unmet need for monitoring products that are small, simple to use and cost effective with improved functionality. Sphere Medical's products can be used in a wide range of medical applications enabling faster clinical decision making and consequently improved patient outcomes, whilst also reducing costs for healthcare payers.
Sphere Medical is headquartered in Cambridge, UK and employs around 60 people. The Company has existing commercial partnerships with the leading global medical device companies. For further information, please visit www.spheremedical.com
Follow the stocks
